Jun Yong Choi
Overview
Explore the profile of Jun Yong Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
406
Citations
4502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation
de Waal R, Wools-Kaloustian K, Brazier E, Althoff K, Jaquet A, Duda S, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39501773
Background: While people with HIV (PWH) start antiretroviral treatment (ART) regardless of CD4 count, CD4 measurement remains crucial for detecting advanced HIV disease and evaluating ART programmes. We explored CD4...
12.
Lee J, Han M, Ahn S, Lee Y, Yeom J, Choi J, et al.
J Korean Med Sci
. 2024 Oct;
39(41):e263.
PMID: 39468945
Background: Patients with hematologic malignancies exhibit persistent severe acute respiratory syndrome coronavirus 2 positivity over long periods after coronavirus disease 2019 (COVID-19) diagnosis. However, the frequency of, risk factors for,...
13.
Han M, Lee Y, Ahn S, Seong J, Lee J, Lee Y, et al.
Microbiol Spectr
. 2024 Oct;
12(11):e0139924.
PMID: 39404350
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). CP-COV03 is a novel antiviral candidate that significantly enhanced the bioavailability of niclosamide...
14.
Ahn S, Lee Y, Han M, Lee J, Seong J, Baek Y, et al.
Infect Chemother
. 2024 Oct;
56(3):369-377.
PMID: 39370122
Background: While Korea maintains a low prevalence of human immunodeficiency virus (HIV), the number of newly diagnosed cases has been steadily rising, reaching approximately 1,000 annually in recent years. The...
15.
Lee S, Kim H, Kim J, Pyo W, Kim J, Ahn J, et al.
Sci Rep
. 2024 Sep;
14(1):22254.
PMID: 39333363
Patients with diabetes mellitus (DM) are at a higher risk of infectious diseases, and exercise is an important treatment modality for DM. Despite their susceptibility to infection in diabetic patients,...
16.
Lee Y, Lee K, Lee J, Ahn S, Han M, Choi J
Yonsei Med J
. 2024 Sep;
65(10):619-622.
PMID: 39313453
Lenacapavir is a novel, first-in-class, capsid inhibitor, which has been approved as an adjunctive therapy for multidrug-resistant human immunodeficiency virus (HIV)-1 virus in combination with optimized background regimen (OBR). Lenacapavir...
17.
Lee J, Jang H, Ahn S, Seong J, Kim Y, Sohn Y, et al.
Int J Infect Dis
. 2024 Sep;
148:107249.
PMID: 39307179
Objectives: We evaluated the vaccine effectiveness of monovalent XBB.1.5 vaccine against symptomatic COVID-19 infection, hospitalization, and the need for oxygen therapy in South Korea. Design: This study employed a test-negative...
18.
Seong H, Suh J, Choi J, Lee J, Yeom J
Front Public Health
. 2024 Sep;
12:1423004.
PMID: 39238542
Background: malaria has been one of the most troublesome diseases in the Democratic People's Republic of Korea (DPRK). Given that a majority of malaria cases are concentrated near the demilitarized...
19.
Park S, Baek Y, Kim J, Seong H, Kim B, Kim Y, et al.
Infect Chemother
. 2024 Sep;
56(3):308-328.
PMID: 39231504
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management...
20.
Kim J, Seong J, Ahn S, Lee Y, Lee J, Ahn J, et al.
Infect Chemother
. 2024 Sep;
56(3):287-299.
PMID: 39231503
With advancements in antiretroviral therapy (ART), the average lifespan of people with human immunodeficiency virus (HIV) is increasing, as is the number of older adults with HIV. Accordingly, the number...